The airspace around Washington, D.C., is congested and complex — a combination aviation experts have long worried could lead ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

Wednesday’s fatal collision and two other incidents dramatically illustrate the challenges pilots and air traffic controllers face in the complex, security-sensitive skies above the nation’s capital.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The catastrophe immediately raised questions about the close proximity in which helicopters and jetliners soar over the busy ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

Following the deadly midair collision on Wednesday, our investigators found that dozens of close calls have been reported at ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

7:30 a.m.: Local and federal officials hold a news conference at Reagan National Airport, where they say that they do not ...

An expert believes that because a civilian aircraft and military chopper were involved in the air tragedy, the investigation ...